The PET- Retroperitoneal Sarcoma Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Retroperitoneal Sarcoma
Interventions
DEVICE

PET MRI scan

"Standard of care includes a baseline PET-CT and conventional CT after 2 cycles of neoadjuvant chemotherapy, and after 5-6 cycles, of neoadjuvant chemotherapy, as per current practice/ standard of care.~Patients that enroll in the trial will receive two additional PET MRI scans- one at baseline and one after 1 cycle of chemotherapy"

Trial Locations (1)

M5G 1X5

University Health Network and The Sinai Health System, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER